Tactile Systems maintains $16 target despite Medicare challenges

Published 26/08/2024, 21:54
Tactile Systems maintains $16 target despite Medicare challenges

On Monday, BTIG maintained its Buy rating on Tactile Systems Technology (NASDAQ:TCMD), with a steady price target of $16.00. The firm addressed the recent guidance reduction by Tactile Systems, which was attributed to stricter Medicare documentation requirements impacting sales of its Lymphedema products. Tactile Systems had revised its fiscal year 2024 revenue forecast downward by approximately $7 million to a range of $293 million to $298 million, indicating a growth rate between 7% and 9% year over year.

The reduction in guidance by Tactile Systems was partly due to the increasing rates of improper payment identified by CMS RAC audits for pneumatic compression devices. In 2023, an audit revealed that 78.9% of Medicare claims for these devices were improperly paid, either due to insufficient documentation or a lack of medical necessity. However, BTIG notes that these audits represent a very small portion of total Medicare claims, suggesting the impact on Tactile Systems may be minimal.

BTIG questions the extent of the guidance reduction by Tactile Systems, considering the small risk posed by the Medicare audits. The firm speculates whether the front-end documentation requirements might be more challenging than anticipated, but also suggests that the significant guide down could potentially position Tactile Systems to surpass consensus expectations in upcoming quarters.

The investment firm believes that for Tactile Systems' stock to perform well, the company needs to consistently exceed expectations and raise its outlook, particularly by improving patient dynamics outside of the Medicare segment. BTIG's analysis indicates that the valuation of Tactile Systems currently assumes minimal growth, which could mean any positive developments could have a favorable impact on the stock's performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.